Lush Cream contains Luliconazole 1% w/w, an imidazole antifungal agent indicated for the topical treatment of superficial fungal infections of the skin. Luliconazole exhibits broad-spectrum antifungal activity against dermatophytes, yeasts, and molds by inhibiting the biosynthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. This cream is primarily prescribed for conditions such as tinea corporis, tinea cruris, and tinea pedis. Lush Cream is applied once daily to the affected area and surrounding skin after cleansing and drying, typically for a duration of 2 to 4 weeks depending on the severity and location of the infection. It is well-tolerated with a low incidence of adverse effects; however, mild local reactions such as burning, itching, or irritation may occur. The formulation is intended for external use only and should be avoided in patients with known hypersensitivity to luliconazole or any excipients in the cream. Use during pregnancy and lactation should be considered only if the potential benefit justifies the potential risk. Lush Cream offers an effective and convenient treatment option for managing superficial fungal infections, promoting rapid symptom resolution and reducing the risk of recurrence.